Journal article
Survival and desferrioxamine in thalassaemia major.
- Abstract:
- A small randomised trial and observation of all patients homozygous for beta-thalassaemia in Britain born in or before 1963 indicated that those patients who had received average weekly doses of more than 4 g of desferrioxamine over the previous few years were less likely to die in the near future than were patients of similar ages who had received less, or no, desferrioxamine.
- Publication status:
- Published
Actions
Authors
- Journal:
- British medical journal (Clinical research ed.) More from this journal
- Volume:
- 284
- Issue:
- 6322
- Pages:
- 1081-1084
- Publication date:
- 1982-04-01
- ISSN:
-
0267-0623
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:42101
- UUID:
-
uuid:f032844b-3b4c-4848-aaa1-f6ce8426b354
- Local pid:
-
pubs:42101
- Source identifiers:
-
42101
- Deposit date:
-
2012-12-19
- ARK identifier:
Terms of use
- Copyright date:
- 1982
If you are the owner of this record, you can report an update to it here: Report update to this record